Evidence map›Paper›PMID 32161260›Full record

ArticleNature communications2020

Crystal structure of a lipin/Pah phosphatidic acid phosphatase.

Valerie I Khayyo, Reece M Hoffmann, Huan Wang, Justin A Bell, John E Burke, Karen Reue, Michael V Airola

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Nir2 crystal structures reveal a phosphatidic acid-sensing mechanism at ER-PM contact sites.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Architecture and function of yeast phosphatidate phosphatase Pah1 domains/regions.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Role of lipins in cardiovascular diseases.Lipids in health and disease · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Valerie I KhayyoDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.ORCID http://orcid.org/0000-0002-7585-4292
Reece M HoffmannDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 2Y2, Canada.
Huan WangDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-1115-143X
Justin A BellDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.ORCID http://orcid.org/0000-0002-4945-7525
John E BurkeDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 2Y2, Canada.ORCID http://orcid.org/0000-0001-7904-9859
Karen ReueDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Michael V AirolaDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA. michael.airola@stonybrook.edu.ORCID http://orcid.org/0000-0003-4981-1253
Stony Brook University · USUniversity of California, Los Angeles · USUniversity of Victoria · CA

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUE, KAREN · 1985 to 2019
$50.2M
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Structure and regulation of lipid metabolism and transportR35GM128666 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Michael Virgil Airola · 2018 to 2026
$4.0M
Multiphoton Microscope for Deep Tissue ImagingS10OD025017 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BENTOLILA, LAURENT A. · 2018 to 2018
$599k
CIHRNHLBI NIH HHS P01 HL028481NHLBI NIH HHS P01 HL090553NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R35 GM128666NIH HHS S10 OD025017
6 · The paper itself

Abstract

Lipin/Pah phosphatidic acid phosphatases (PAPs) generate diacylglycerol to regulate triglyceride synthesis and cellular signaling. Inactivating mutations cause rhabdomyolysis, autoinflammatory disease, and aberrant fat storage. Disease-mutations cluster within the conserved N-Lip and C-Lip regions that are separated by 500-residues in humans. To understand how the N-Lip and C-Lip combine for PAP function, we determined crystal structures of Tetrahymena thermophila Pah2 (Tt Pah2) that directly fuses the N-Lip and C-Lip. Tt Pah2 adopts a two-domain architecture where the N-Lip combines with part of the C-Lip to form an immunoglobulin-like domain and the remaining C-Lip forms a HAD-like catalytic domain. An N-Lip C-Lip fusion of mouse lipin-2 is catalytically active, which suggests mammalian lipins function with the same domain architecture as Tt Pah2. HDX-MS identifies an N-terminal amphipathic helix essential for membrane association. Disease-mutations disrupt catalysis or destabilize the protein fold. This illustrates mechanisms for lipin/Pah PAP function, membrane association, and lipin-related pathologies.

Indexed as

Catalytic DomainCrystallography, X-RayHEK293 CellsHumansPhosphatidate PhosphataseProtein Conformation, alpha-HelicalProtozoan ProteinsRecombinant ProteinsTetrahymena thermophilaTransfectionLipin 2 protein, mousePhosphatidate Phosphatasephosphatidic acid phosphatase type 2Protozoan ProteinsRecombinant Proteins

Identifiers

PMID32161260
PMCPMC7066176
OpenAlexW3011315437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.